NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Facing the Reality of Drug-Resistant Tuberculosis in India

Facing the Reality of Drug-Resistant Tuberculosis in India

Challenges and Potential Solutions

Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research


Washington (DC): National Academies Press (US); .
ISBN-13: 978-0-309-21966-2ISBN-10: 0-309-21966-3


Presentations at the workshop addressed the following topics: TB (tuberculosis) and MDR (multi-drug resistant) TB in India, including local and national responses to the epidemic (Chapter 2); the global burden of TB and drug-resistant TB, including data from another high-burden country, China (Chapter 3); prevention of the transmission of drug-resistant TB in India (Chapter 4); rapid methods of detecting drug resistance and strengthening laboratory capacity (Chapter 5); approaches to reaching vulnerable populations affected by drug-resistant TB (Chapter 6); public–private engagement and innovative methods in combating drug-resistant TB (Chapter 7); the drug supply chain for second-line drugs (Chapter 8); and the major viewpoints expressed at the workshop and next steps suggested by workshop participants (Chapter 9).


Rapporteurs: Steve Olson, Rebecca A. English, Rita S. Guenther, Anne B. Claiborne

This study was supported by contracts between the National Academy of Sciences and Department of Health and Human Services (Contract Nos. N01-OD-4-2139 and 223001003T), U.S. State Department (S-LMAQM-08-GR-071), American Society for Microbiology, Amgen Inc., Association of American Medical Colleges, Bristol-Myers Squibb, Burroughs Wellcome Fund, Celtic Therapeutics, LLLP, Critical Path Institute, Doris Duke Charitable Foundation, Eli Lilly & Co., FasterCures, Foundation for the NIH, Friends of Cancer Research, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, and Pfizer Inc.

Suggested citation:

IOM (Institute of Medicine). 2012. Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop. Washington, DC: The National Academies Press.

The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the project.

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.

Copyright © 2012, National Academy of Sciences.
Bookshelf ID: NBK92617PMID: 22973580
PubReader format: click here to try


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.5M)

Related information

Related citations in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...